Circulation, Vol 82, 394-406, Copyright © 1990 by American Heart Association
TJ Cohen and LB Liem
Current automatic implantable cardioverter-defibrillators detect
tachyarrhythmias primarily by rate-only algorithms and cannot adequately
distinguish hemodynamically stable from unstable tachyarrhythmias. The
responses of right atrial (mean) and right ventricular pressures (mean,
systolic, diastolic, and pulse) to 64 induced and paced supraventricular
and ventricular tachyarrhythmias were studied in 10 patients (left
ventricular ejection fraction of 32 +/- 6%) to develop an algorithm capable
of differentiating stable from unstable rhythms. Tachyarrhythmias were
defined as hemodynamically unstable when mean arterial pressure decreased
by 25 mm Hg or more during 15 seconds. Mean right atrial, right ventricular
systolic, and right ventricular pulse pressures were found to be useful in
distinguishing the hemodynamic significance of a tachyarrhythmia. A
combined detection algorithm was developed that identified a
hemodynamically unstable rhythm when the heart rate was 150 beats/min or
more and mean right atrial pressure increased by 4 mm Hg or more and right
ventricular systolic pressure decreased by 5 mm Hg or more during 15
seconds. This algorithm was then applied to the next 20 consecutive
patients (left ventricular ejection fraction of 34 +/- 4%) and compared
with the current rate-only algorithm (heart rate of 150 beats/min or more)
in 143 tachyarrhythmias, and the sensitivity and specificity for detection
of hemodynamically unstable tachyarrhythmias were determined. The rate-only
detection algorithm had 100% sensitivity but only 68% specificity for
detection of unstable tachyarrhythmias, whereas the combined rate-mean
right atrial pressure-right ventricular systolic pressure detection
algorithm had sensitivity and specificity of 100%. Therefore, the
performance of an antitachycardia system may be significantly improved by
detection algorithms that integrate hemodynamic and rate criteria.
ARTICLES
A hemodynamically responsive antitachycardia system. Development and basis for design in humans
Cardiology Division, Stanford University Medical Center, Calif.
This article has been cited by other articles:
![]() |
C.M Pratt, A.J Camm, J.T Bigger Jr, G Breithardt, R.W.F Campbell, A.E Epstein, L.J Kappenberger, K.-H Kuck, S Pocock, S Saksena, et al. Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems? Eur. Heart J., November 1, 1999; 20(21): 1538 - 1552. [Abstract] [PDF] |
||||
![]() |
M. Nair, N. Saoudi, D. Kroiss, and B. Letac Automatic Arrhythmia Identification Using Analysis of the Atrioventricular Association: Application to a New Generation of Implantable Defibrillators Circulation, February 18, 1997; 95(4): 967 - 973. [Abstract] [Full Text] |
||||
![]() |
S. L. Pinski and G. J. Fahy The Proarrhythmic Potential of Implantable Cardioverter-Defibrillators Circulation, September 15, 1995; 92(6): 1651 - 1664. [Abstract] [Full Text] |
||||
![]() |
T. J. Cohen, P. R. Reid, M. M. Mower, M. Mirowski, D. Aarons, J. Juanteguy, and E. P. Veltri The Automatic Implantable Cardioverter-Defibrillator: Long-term Clinical Experience and Outcome at a Hospital Without an Open-Heart Surgery Program Arch Intern Med, January 1, 1992; 152(1): 65 - 69. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |